Connection

HANUMANTHA PULIVARTHI to Tumor Cells, Cultured

This is a "connection" page, showing publications HANUMANTHA PULIVARTHI has written about Tumor Cells, Cultured.
Connection Strength

0.457
  1. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer. 2003 Mar; 36(3):233-41.
    View in: PubMed
    Score: 0.089
  2. Genome-wide screening for radiation response factors in head and neck cancer. Laryngoscope. 2000 Aug; 110(8):1251-6.
    View in: PubMed
    Score: 0.074
  3. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. Anticancer Res. 2009 Apr; 29(4):1255-62.
    View in: PubMed
    Score: 0.034
  4. i(5p) and del(6q) are nonrandom abnormalities in carcinoma cervix uteri. Cytogenetics of two newly developed cell lines. Cancer Genet Cytogenet. 1994 Aug; 76(1):56-8.
    View in: PubMed
    Score: 0.024
  5. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes. Cancer Res. 2002 Nov 01; 62(21):6218-23.
    View in: PubMed
    Score: 0.022
  6. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002 Aug; 1(10):769-76.
    View in: PubMed
    Score: 0.021
  7. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev. 2002 Apr 15; 16(8):984-93.
    View in: PubMed
    Score: 0.021
  8. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes Cancer. 2002 Feb; 33(2):123-32.
    View in: PubMed
    Score: 0.021
  9. Spectral karyotyping analysis of head and neck squamous cell carcinoma. Laryngoscope. 2001 Sep; 111(9):1545-50.
    View in: PubMed
    Score: 0.020
  10. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res. 2001 Jun 01; 61(11):4506-13.
    View in: PubMed
    Score: 0.020
  11. An apparent interlocus gene conversion-like event at a putative tumor suppressor gene locus on human chromosome 6q27 in a Burkitt's lymphoma cell line. DNA Res. 2000 Aug 31; 7(4):261-72.
    View in: PubMed
    Score: 0.019
  12. Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors. Genes Chromosomes Cancer. 2000 Aug; 28(4):395-403.
    View in: PubMed
    Score: 0.019
  13. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet. 1997 Oct; 17(2):226-30.
    View in: PubMed
    Score: 0.015
  14. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995 Oct 01; 86(7):2708-14.
    View in: PubMed
    Score: 0.013
  15. Consistent chromosomal losses in head and neck squamous cell carcinoma cell lines. Genes Chromosomes Cancer. 1994 Sep; 11(1):29-39.
    View in: PubMed
    Score: 0.012
  16. Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene. 2003 May 29; 22(22):3489-99.
    View in: PubMed
    Score: 0.011
  17. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity. 2001 Mar; 14(3):277-89.
    View in: PubMed
    Score: 0.010
  18. Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. DNA Seq. 1998; 9(4):189-204.
    View in: PubMed
    Score: 0.008
  19. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood. 1992 Oct 01; 80(7):1781-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.